The DOI matches its Crossref record; 241 of the 241 references it cites were found in a registry or an index.
MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management
Open accessAbstract
Osteoporosis is a skeletal disorder characterized by decreased mass and compromised bone strength predisposing to an increased risk of fractures. Although idiopathic osteoporosis is the most common form of osteoporosis, secondary factors may contribute to the bone loss and increased fracture risk in patients presenting with fragility fractures or osteoporosis. Several medical conditions and medications significantly increase the risk for bone loss and skeletal fragility. This review focuses on some of the common causes of osteoporosis, addressing the underlying mechanisms, diagnostic approach and treatment of low bone mass in the presence of these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
The International Myeloma Working Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04355.x · Cited by 2,321
Vestergaard, P. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0253-4 · Cited by 1,808
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
Risk of Fracture after Androgen Deprivation for Prostate Cancer
Shahinian, V. B., Kuo, Y.-F., Freeman, J. L., & Goodwin, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041943 · Cited by 1,375
Use of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Self-citationThe Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Self-citationRecommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794
Grossman, J. M., Gordon, R., Ranganath, V. K., Deal, C., Caplan, L., Chen, W., Curtis, J. R., Furst, D. E., McMahon, M., Patkar, N. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20295 · Cited by 708
TSH Is a Negative Regulator of Skeletal Remodeling
Abe, E., Marians, R. C., Yu, W., Wu, X.-B., Ando, T., Li, Y., Iqbal, J., Eldeiry, L., Rajendren, G., Blair, H. C., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00771-2 · Cited by 691
Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome
Legro, R. S., Brzyski, R. G., Diamond, M. P., Coutifaris, C., Schlaff, W. D., Casson, P., Christman, G. M., Huang, H., Yan, Q., Alvero, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313517 · Cited by 672
Estimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620
Type 1 and Type 2 Diabetes and Incident Hip Fractures in Postmenopausal Women
Nicodemus, K. K., & Folsom, A. R. (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1192 · Cited by 568
Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559
Long-term effect of testosterone therapy on bone mineral density in hypogonadal men
Behre, H. M., Kliesch, S., Leifke, E., Link, T. M., & Nieschlag, E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4163 · Cited by 559
Reid, D. M., Devogelaer, J.-P., Saag, K., Roux, C., Lau, C.-S., Reginster, J.-Y., Papanastasiou, P., Ferreira, A., Hartl, F., Fashola, T., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60250-6 · Cited by 527
PPAR-γ regulates osteoclastogenesis in mice
Wan, Y., Chong, L.-W., & Evans, R. M. (2007) · Nature Medicine · doi:10.1038/nm1672 · Cited by 517
Cytochrome P450-mediated metabolism of vitamin D
Jones, G., Prosser, D. E., & Kaufmann, M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r031534 · Cited by 503
Thiazolidinedione Use and Bone Loss in Older Diabetic Adults
Schwartz, A. V., Sellmeyer, D. E., Vittinghoff, E., Palermo, L., Lecka-Czernik, B., Feingold, K. R., Strotmeyer, E. S., Resnick, H. E., Carbone, L., Beamer, B. A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2226 · Cited by 500
Zhang, Y.-H., Heulsmann, A., Tondravi, M. M., Mukherjee, A., & Abu-Amer, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008198200 · Cited by 498
Triant, V. A., Brown, T. T., Lee, H., & Grinspoon, S. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0828 · Cited by 490
Risk for fracture in women with low serum levels of thyroid-stimulating hormone
Bauer, D. C., Ettinger, B., Nevitt, M. C., Stone, K. L., & for the Study of Osteoporotic Fractures Research Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00009 · Cited by 467
Canalis, E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3441 · Cited by 463
Self-citationRosiglitazone Causes Bone Loss in Mice by Suppressing Osteoblast Differentiation and Bone Formation
Ali, A. A., Weinstein, R. S., Stewart, S. A., Parfitt, A. M., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2004-0735 · Cited by 444
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Use of proton pump inhibitors and risk of osteoporosis-related fractures
Targownik, L. E., Lix, L. M., Metge, C. J., Prior, H. J., Leung, S., & Leslie, W. D. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071330 · Cited by 436
Mahida, Y. R., Wu, K., & Jewell, D. P. (1989) · Gut · doi:10.1136/gut.30.6.835 · Cited by 427
TBS (Trabecular Bone Score) and Diabetes-Related Fracture Risk
Leslie, W. D., Aubry-Rozier, B., Lamy, O., Hans, D., & Program, F. T. M. B. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3118 · Cited by 426
Coleman, R. E., Banks, L. M., Girgis, S. I., Kilburn, L. S., Vrdoljak, E., Fox, J., Cawthorn, S. J., Patel, A., Snowdon, C. F., Hall, E., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70003-7 · Cited by 426
Primary Hyperparathyroidism and the Risk of Fracture: A Population-Based Study
Khosla, S., Melton, L. J., Wermers, R. A., Crowson, C. S., O'Fallon, W. M., & Riggs, B. L. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.10.1700 · Cited by 416
AGA technical review on osteoporosis in gastrointestinal diseases
Bernstein, C. N., Leslie, W. D., & Leboff, M. S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50106 · Cited by 412
Bone Loss after Initiation of Androgen Deprivation Therapy in Patients with Prostate Cancer
Greenspan, S. L., Coates, P., Sereika, S. M., Nelson, J. B., Trump, D. L., & Resnick, N. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0183 · Cited by 411
Terpos, E., Szydlo, R., Apperley, J. F., Hatjiharissi, E., Politou, M., Meletis, J., Viniou, N., Yataganas, X., Goldman, J. M., & Rahemtulla, A. (2003) · Blood · doi:10.1182/blood-2003-02-0380 · Cited by 410
Glucocorticoids suppress bone formation via the osteoclast.
Kim, H.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28084 · Cited by 384
Dahlman, T. C. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90378-v · Cited by 379
Smith, M. R., Lee, W. C., Brandman, J., Wang, Q., Botteman, M., & Pashos, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6908 · Cited by 366
Angeli, A., Guglielmi, G., Dovio, A., Capelli, G., de Feo, D., Giannini, S., Giorgino, R., Moro, L., & Giustina, A. (2006) · Bone · doi:10.1016/j.bone.2006.02.005 · Cited by 365
Monréal, M., Lafoz, E., Olivé, A., et al. (1994) · PubMed · Cited by 352
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2
Oshima, T., Abe, M., Asano, J., Hara, T., Kitazoe, K., Sekimoto, E., Tanaka, Y., Shibata, H., Hashimoto, T., Ozaki, S., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4940 · Cited by 345
Prospective Study of Diabetes and Risk of Hip Fracture
Janghorbani, M., Feskanich, D., Willett, W. C., & Hu, F. (2006) · Diabetes Care · doi:10.2337/dc06-0440 · Cited by 340
Joint IOF-ECTS GIO Guidelines Working Group, Lekamwasam, S., Adachi, J. D., Agnusdei, D., Bilezikian, J., Boonen, S., Borgström, F., Cooper, C., Diez Perez, A., Eastell, R., et al. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1958-1 · Cited by 335
Fracture Risk With Multiple Myeloma: A Population-Based Study
Melton, L. J., Kyle, R. A., Achenbach, S. J., Oberg, A. L., & Rajkumar, S. V. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041131 · Cited by 332
Gray, S. L. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.94 · Cited by 329
Eastell, R., Hannon, R. A., Cuzick, J., Dowsett, M., Clack, G., & Adams, J. E. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060508 · Cited by 325
Guidance for the adjustment of FRAX according to the dose of glucocorticoids
Kanis, J. A., Johansson, H., Oden, A., & McCloskey, E. V. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1524-7 · Cited by 323
Buckley, L. M., Leib, E. S., Cartularo, K. S., Vacek, P. M., & Cooper, S. M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00004 · Cited by 310
Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches
Canalis, E. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.154 · Cited by 304
Self-citationEffects of inhaled glucocorticoids on bone density in premenopausal women.
Israel, E., Banerjee, T. R., Fitzmaurice, G. M., Kotlov, T. V., LaHive, K., & LeBoff, M. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002304 · Cited by 303
Greenspan, S. L., Nelson, J. B., Trump, D. L., & Resnick, N. M. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-6-200703200-00006 · Cited by 302
Monreal, M., Lafoz, E., Olive, A., del Rio, L., & Vedia, C. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642376 · Cited by 299
Fracture risk with intermittent high‐dose oral glucocorticoid therapy
De Vries, F., Bracke, M., Leufkens, H. G. M., Lammers, J. J., Cooper, C., & Van Staa, T. P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22294 · Cited by 298
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism
Vestergaard, P. (2000) · BMJ · doi:10.1136/bmj.321.7261.598 · Cited by 290
Vestergaard, P., & Mosekilde, L. (2002) · Thyroid · doi:10.1089/105072502760043503 · Cited by 289
Differential Effects of Androgens and Estrogens on Bone Turnover in Normal Men
Leder, B. Z., LeBlanc, K. M., Schoenfeld, D. A., Eastell, R., & Finkelstein, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021036 · Cited by 283
Leidig-Bruckner, G., Hosch, S., Dodidou, P., Ritschel, D., Conradt, C., Klose, C., Otto, G., Lange, R., Theilmann, L., Zimmerman, R., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03641-2 · Cited by 267
The molecular actions of thyroid hormone in bone
Duncan Bassett, J. H., & Williams, G. R. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00144-9 · Cited by 261
Townsend, M. F., Sanders, W. H., Northway, R. O., & Graham, S. D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<545::aid-cncr17>3.0.co;2-3 · Cited by 260
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
RANK ligand and osteoprotegerin in myeloma bone disease.
Sezer, O., Heider, U., Zavrski, I., Kühne, C. A., & Hofbauer, L. C. (2003) · Blood · doi:10.1182/blood-2002-09-2684 · Cited by 258
Smith, M. R., Fallon, M. A., Lee, H., & Finkelstein, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032058 · Cited by 248
Vis, M., Havaardsholm, E. A., Haugeberg, G., Uhlig, T., Voskuyl, A. E., van de Stadt, R. J., Dijkmans, B. A. C., Woolf, A. D., Kvien, T. K., & Lems, W. F. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044198 · Cited by 246
Inflammatory bowel disease and the risk of fracture
Van staa, T.-P., Cooper, C., Samuels Brusse, L., Leufkens, H., Javaid, M. K., & Arden, N. K. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.027 · Cited by 245
Mechanism of acid-induced bone resorption
Krieger, N. S., Frick, K. K., & Bushinsky, D. A. (2004) · Current Opinion in Nephrology and Hypertension · doi:10.1097/01.mnh.0000133975.32559.6b · Cited by 241
Bone mineral density assessment in children with inflammatory bowel disease☆☆☆
Gokhale, R., Favus, M. J., Karrison, T., Sutton, M. M., Rich, B., & Kirschner, B. S. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70309-9 · Cited by 230
Osteoporosis in a North American adult population with celiac disease1
Meyer, D., Stavropolous, S., Diamond, B., Shane, E., & Green, P. H. R. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03507.x · Cited by 228
Vitamin D Deficiency and Bone Disease in Patients With Crohn's Disease
Driscoll, R. H., Meredith, S. C., Sitrin, M., & Rosenberg, I. H. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80135-2 · Cited by 212
Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.
Adachi, J. D., Wg, B., Bianchi, F. A., Cividino, A. A., Pillersdorf, S., Sebaldt, R. J., Tugwell, P., Gordon, M., Steele, M., Webber, C., et al. (1996) · PubMed · Cited by 209
Meta-Analysis of Randomized Trials for Medical Prevention of Calcium Oxalate Nephrolithiasis
PEARLE, M. S., ROEHRBORN, C. G., & PAK, C. Y. C. (1999) · Journal of Endourology · doi:10.1089/end.1999.13.679 · Cited by 209
Association between iron overload and osteoporosis in patients with hereditary hemochromatosis
Valenti, L., Varenna, M., Fracanzani, A. L., Rossi, V., Fargion, S., & Sinigaglia, L. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0701-4 · Cited by 203
Bida, J. P., Kyle, R. A., Therneau, T. M., Melton, L. J., Plevak, M. F., Larson, D. R., Dispenzieri, A., Katzmann, J. A., & Rajkumar, S. V. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.8.685 · Cited by 202
Miao, C.-G., Yang, Y.-Y., He, X., Li, X.-F., Huang, C., Huang, Y., Zhang, L., Lv, X.-W., Jin, Y., & Li, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.04.002 · Cited by 201
Cooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200
Vitamin D deficiency in patients with active systemic lupus erythematosus
Borba, V. Z. C., Vieira, J. G. H., Kasamatsu, T., Radominski, S. C., Sato, E. I., & Lazaretti-Castro, M. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0676-1 · Cited by 199
Fracture risk is increased in epilepsy
Vestergaard, P., Tigaran, S., Rejnmark, L., Tigaran, C., Dam, M., & Mosekilde, L. (1999) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00675.x · Cited by 197
Gonadal and Adrenal Androgens Are Potent Regulators of Human Bone Cell Metabolism In Vitro
Kasperk, C. H., Wakley, G. K., Hierl, T., & Ziegler, R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.3.464 · Cited by 196
Terpos, E., Christoulas, D., Katodritou, E., Bratengeier, C., Gkotzamanidou, M., Michalis, E., Delimpasi, S., Pouli, A., Meletis, J., Kastritis, E., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27342 · Cited by 184
Bone Turnover, Bone Mineral Density, and Fracture Risk in Acromegaly: A Meta-Analysis
Mazziotti, G., Biagioli, E., Maffezzoni, F., Spinello, M., Serra, V., Maroldi, R., Floriani, I., & Giustina, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2937 · Cited by 183
Geusens, P. P., Landewé, R. B. M., Garnero, P., Chen, D., Dunstan, C. R., Lems, W. F., Stinissen, P., van der Heijde, D. M. F. M., van der Linden, S., & Boers, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21896 · Cited by 182
Effects of warfarin on bone. Studies on the vitamin K-dependent protein of rat bone.
Price, P. A., & Williamson, M. K. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42959-6 · Cited by 182
Bone disease and skeletal complications in patients with β thalassemia major
Haidar, R., Musallam, K. M., & Taher, A. T. (2010) · Bone · doi:10.1016/j.bone.2010.10.173 · Cited by 176
Anti-epileptic medication and bone health
Petty, S. J., O’Brien, T. J., & Wark, J. D. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0185-z · Cited by 174
Vertebral Fractures in Patients With Acromegaly: A 3-Year Prospective Study
Mazziotti, G., Bianchi, A., Porcelli, T., Mormando, M., Maffezzoni, F., Cristiano, A., Giampietro, A., De Marinis, L., & Giustina, A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1460 · Cited by 172
Misra, M., & Klibanski, A. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0039 · Cited by 171
Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone
Cooper, M. S., Walker, E. A., Bland, R., Fraser, W. D., Hewison, M., & Stewart, P. M. (2000) · Bone · doi:10.1016/s8756-3282(00)00344-6 · Cited by 170
Douketis, J. D., Ginsberg, J. S., Burrows, R. F., Duku, E., Webber, C. E., & Brill-Edwards, P. A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650255 · Cited by 169
Role of bone in regulation of systemic acid-base balance
Green, J., & Kleeman, C. R. (1991) · Kidney International · doi:10.1038/ki.1991.2 · Cited by 166
Antiepileptic drug use increases rates of bone loss in older women: A prospective study
Ensrud, K. E., Walczak, T. S., Blackwell, T., Ensrud, E. R., Bowman, P. J., & Stone, K. L. (2004) · Neurology · doi:10.1212/01.wnl.0000125185.74276.d2 · Cited by 165
Pereira, R. C., Delany, A. M., & Canalis, E. (2002) · Bone · doi:10.1016/s8756-3282(02)00687-7 · Cited by 165
Self-citationSmith, E., & Frenkel, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m406294200 · Cited by 165
Mechanisms of glucocorticoid-induced osteoporosis.
Canalis, E. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200307000-00013 · Cited by 164
Self-citationPathophysiology of bone loss in patients receiving anticonvulsant therapy
Fitzpatrick, L. A. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.11.026 · Cited by 162
van Diepen, S., Majumdar, S. R., Bakal, J. A., McAlister, F. A., & Ezekowitz, J. A. (2008) · Circulation · doi:10.1161/circulationaha.108.784009 · Cited by 162
Fracture Risk in Monoclonal Gammopathy of Undetermined Significance
Melton, L. J., Rajkumar, S. V., Khosla, S., Achenbach, S. J., Oberg, A. L., & Kyle, R. A. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301212 · Cited by 161
Dovio, A., Perazzolo, L., Osella, G., Ventura, M., Termine, A., Milano, E., Bertolotto, A., & Angeli, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0164 · Cited by 161
Calcineurin regulates bone formation by the osteoblast
Sun, L., Blair, H. C., Peng, Y., Zaidi, N., Adebanjo, O. A., Wu, X. B., Wu, X. Y., Iqbal, J., Epstein, S., Abe, E., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508480102 · Cited by 159
Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo
Muir, J., Andrew, M., Hirsh, J., Weitz, J., Young, E., Deschamps, P., & Shaughnessy, S. (1996) · Blood · doi:10.1182/blood.v88.4.1314.bloodjournal8841314 · Cited by 157
Critical role of the hypothalamic–pituitary–thyroid axis in bone
Bassett, J. H. D., & Williams, G. R. (2008) · Bone · doi:10.1016/j.bone.2008.05.007 · Cited by 156
Habib, Z. A., Havstad, S. L., Wells, K. E., Divine, G., Pladevall, M., & Williams, L. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1385 · Cited by 154
Androgen effects on bone metabolism: recent progress and controversies
Hofbauer, L. C., & Khosla, S. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400271 · Cited by 154
Warfarin Use and Risk for Osteoporosis in Elderly Women
Jamal, S. A., Browner, W. S., Bauer, D. C., & Cummings, S. R. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-10-199805150-00006 · Cited by 153
Glucocorticoid Suppression of IGF I Transcription in Osteoblasts
Delany, A. M., Durant, D., & CANALIS, E. M. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0704 · Cited by 153
Self-citationDouketis, J. D., Ginsberg, J. S., Burrows, R. F., et al. (1996) · PubMed · Cited by 149
Bone density recovery after depot medroxyprogesterone acetate injectable contraception use
Kaunitz, A. M., Arias, R., & McClung, M. R. (2008) · Contraception · doi:10.1016/j.contraception.2007.10.005 · Cited by 149
Dennison, E. M., Compston, J. E., Flahive, J., Siris, E. S., Gehlbach, S. H., Adachi, J. D., Boonen, S., Chapurlat, R. D., Díez‐Pérez, A., Anderson, F. A., et al. (2012) · Bone · doi:10.1016/j.bone.2012.02.639 · Cited by 148
Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland
Huusko, T., Korpela, M. M., Karppi, P., Avikainen, V., Kautiainen, H., & Sulkava, R. O. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.5.521 · Cited by 147
Incident fractures in HIV-infected individuals
Shiau, S., Broun, E. C., Arpadi, S. M., & Yin, M. T. (2013) · AIDS · doi:10.1097/qad.0b013e328361d241 · Cited by 147
Lauderdale, D. S., Thisted, R. A., Wen, M., & Favus, M. J. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1893 · Cited by 146
Fraser, L.-A., Leslie, W. D., Targownik, L. E., Παπαϊωάννου, Α., & Adachi, J. D. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2112-9 · Cited by 145
Testosterone, Bone and Osteoporosis
Tuck, S. P., & Francis, R. M. (2008) · Frontiers of hormone research · doi:10.1159/000176049 · Cited by 144
Heemstra, K. A., Hamdy, N. A. T., Romijn, J. A., & Smit, J. W. A. (2006) · Thyroid · doi:10.1089/thy.2006.16.583 · Cited by 144
Zein, C. O., Jorgensen, R. A., Clarke, B., Wenger, D. E., Keach, J. C., Angulo, P., & Lindor, K. D. (2005) · Hepatology · doi:10.1002/hep.20866 · Cited by 142
Guañabens, N., Cerdá, D., Monegal, A., Pons, F., Caballería, L., Peris, P., & Parés, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.016 · Cited by 142
Androgens suppress osteoclast formation induced by RANKL and macrophage colony-stimulating factor.
Huber, D. M., Bendixen, A. C., Pathrose, P., Srivastava, S., Dienger, K. M., Shevde, N. K., & Pike, J. W. (2001) · Endocrinology · doi:10.1210/endo.142.9.8402 · Cited by 141
Mazziotti, G., Bianchi, A., Bonadonna, S., Nuzzo, M., Cimino, V., Fusco, A., De Marinis, L., & Giustina, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060112 · Cited by 141
Myeloma cells suppress osteoblasts through sclerostin secretion
Colucci, S. C., Brunetti, G., Oranger, A., Mori, G., Sardone, F., Specchia, G., Rinaldi, E., Curci, P., Liso, V., Passeri, G., et al. (2011) · Blood Cancer Journal · doi:10.1038/bcj.2011.22 · Cited by 141
Secondary Osteoporosis: A Review of The Recent Evidence
Painter, S., Kleerekoper, M., & Camacho, P. M. (2006) · Endocrine Practice · doi:10.4158/ep.12.4.436 · Cited by 140
High prevalence of bone disorders after gastrectomy
Zittel, T. T., Zeeb, B., Maier, G. W., Kaiser, G., Zwirner, M., Liebich, H. M., Starlinger, M. J., & Becker, H. D. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00123-2 · Cited by 140
The effects of heparin and low molecular weight heparins on bone
Rajgopal, R., Bear, M., Butcher, M. K., & Shaughnessy, S. G. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2006.10.025 · Cited by 135
Bisphosphonates in multiple myeloma: a network meta-analysis
Mhaskar, R., Redzepovic, J., Wheatley, K., Clark, O. A. C., Miladinovic, B., Glasmacher, A., Kumar, A., & Djulbegovic, B. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003188.pub3 · Cited by 130
Prevalence and predictors of fragility fractures in systemic lupus erythematosus
Yee, C., Crabtree, N. J., Skan, J., Amft, N., Bowman, S., Situnayake, D., & Gordon, C. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018127 · Cited by 130
Paganelli, M., Albanese, C. V., Borrelli, O., Civitelli, F. S., Canitano, N., Viola, F., Passariello, R., & Cucchiara, S. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20039 · Cited by 130
Celiac Disease and Bone Fractures: A Systematic Review and Meta-Analysis
Heikkilä, K., Pearce, J., Mäki, M., & Kaukinen, K. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1858 · Cited by 130
Barbour, K. E., Lui, L., Ensrud, K. E., Hillier, T. A., LeBlanc, E. S., Ing, S. W., Hochberg, M. C., & Cauley, J. A. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2245 · Cited by 129
Carey, E. J., Balan, V., Kremers, W. K., & Hay, J. E. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50242 · Cited by 128
Approach to the Patient with Transplantation-Related Bone Loss
Ebeling, P. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0205 · Cited by 127
Khan, A. A., Grey, A. B., & Shoback, D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1762 · Cited by 125
Bone Disease in CKD: A Focus on Osteoporosis Diagnosis and Management
Miller, P. D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.12.018 · Cited by 124
Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus
Leidig‐Bruckner, G., Grobholz, S., Bruckner, T. M., Scheidt‐Nave, C., Nawroth, P. P., & Schneider, J. G. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-33 · Cited by 124
Androgens regulate bone resorption activity of isolated osteoclasts in vitro
Pederson, L., Kremer, M., Judd, J., Pascoe, D., Spelsberg, T. C., Riggs, B. L., & Oursler, M. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.505 · Cited by 123
Rossini, M., Zanotti, R., Bonadonna, P., Artuso, A., Caruso, B., Schena, D., Vecchiato, D., Bonifacio, M., Viapiana, O., Gatti, D., et al. (2011) · Bone · doi:10.1016/j.bone.2011.07.004 · Cited by 123
Eom, C.-S., Lee, H.-K., Ye, S., Park, S. M., & Cho, K.-H. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1554 · Cited by 123
Risk of bone loss in men with multiple sclerosis
Weinstock‐Guttman, B., Gallagher, E., Baier, M. L., Green, L., Feichter, J., Patrick, K., Miller, C., Wrest, K., & Ramanathan, M. K. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms993oa · Cited by 122
Rejnmark, L., Vestergaard, P., Heickendorff, L., Andreasen, F., & Mosekilde, L. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051003 · Cited by 121
Guañabens, N., Parés, A., Ros, I., Alvarez, L., Pons, F., Caballería, L., Monegal, A., de Osaba, J. M. M., Roca, M., Peris, P., et al. (2003) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07639.x · Cited by 119
Faje, A. T., Karim, L., Taylor, A., Lee, H., Miller, K. K., Mendes, N., Meenaghan, E. M., Goldstein, M. A., Bouxsein, M., Misra, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4153 · Cited by 117
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie, A., Takami, M., Kubo, H., Sekino-Suzuki, N., Kasahara, K., & Sanai, Y. (2007) · Bone · doi:10.1016/j.bone.2007.04.190 · Cited by 116
Kristinsson, S. Y., Tang, M., Pfeiffer, R. M., Björkholm, M., Blimark, C. H., Mellqvist, U., Wåhlin, A., Turesson, I., & Landgren, O. (2010) · Blood · doi:10.1182/blood-2010-04-282848 · Cited by 113
Haroon, N. N., Sriganthan, J., Ghanim, N. A., Inman, R. D., & Cheung, A. M. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.05.008 · Cited by 113
Abrahamsen, B., Jørgensen, H. L., Laulund, A. S., Nybo, M., Brix, T. H., & Hegedüs, L. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2244 · Cited by 112
Shen, C., Chen, F., Zhang, Y., Guo, Y. C., & Ding, M. (2014) · Bone · doi:10.1016/j.bone.2014.04.018 · Cited by 111
Giuliani, N., Morandi, F., Tagliaferri, S., Lazzaretti, M., Donofrío, G., Bonomini, S., Sala, R., Mangoni, M., & Rizzoli, V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4666 · Cited by 111
Krupski, T. L., Smith, M. R., Lee, W. C., Pashos, C. L., Brandman, J., Wang, Q. L., Botteman, M. F., & Litwin, M. S. (2004) · Cancer · doi:10.1002/cncr.20388 · Cited by 109
IL-1 and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase.
Kumar, S., Votta, B. J., Rieman, D. J., Badger, A. M., Gowen, M., & Lee, J. C. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1082 · Cited by 107
Serum Interleukin-6 Reflects Disease Severity and Osteoporosis in Mastocytosis Patients
Theoharides, T. C., Boucher, W. S., & Spear, K. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000063858 · Cited by 106
Hamilton, E. J., Ghasemzadeh, A., Gianatti, E., Joon, D. L., Bolton, D. M., Zebaze, R. M. D., Seeman, E., Zajac, J. D., & Grossmann, M. (2010) · Endocrinology · doi:10.1210/jc.2010-0902 · Cited by 106
Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria
Weisinger, J. R., Alonzo, E., Bellorín-Font, E., Blasini, A. M., Rodriguez, M. A., PAZ-MARTINEZ, V., & Martinis, R. (1996) · Kidney International · doi:10.1038/ki.1996.34 · Cited by 102
Lim, L. S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.7.735 · Cited by 102
Leichtmann, G. A., Bengoa, J., Bolt, M., & Sitrin, M. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.548 · Cited by 101
Bones in coeliac disease: diagnosis and treatment
Corazza, G. R., Stefano, M. D., Mauriño, E. C., & Bai, J. C. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.01.002 · Cited by 101
Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids.
Kipen, Y., Buchbinder, R., Forbes, A. B., Strauss, B. J., Littlejohn, G. O., & Morand, E. F. (1997) · PubMed · Cited by 100
Guañabens, N., Monegal, A., Cerdá, D., Muxí, Á., Gifre, L., Peris, P., & Parés, A. (2013) · Hepatology · doi:10.1002/hep.26466 · Cited by 99
Harper, K. D., & Weber, T. J. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70008-6 · Cited by 99
Fracture risk assessment in patients with chronic kidney disease
Jamal, S. A., West, S., & Miller, P. D. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1781-0 · Cited by 96
Pierce, S. J., Gazvani, M. R., & Farquharson, R. G. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01537-5 · Cited by 92
de Moura, C. S., Bernatsky, S., Abrahamowicz, M., Παπαϊωάννου, Α., Bessette, L., Adachi, J. D., Goltzman, D., Prior, J. C., Kreiger, N., Towheed, T., et al. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2649-x · Cited by 90
Lazzari, A. A., Dussault, P. M., Thakore‐James, M., GAGNON, D. R., Baker, E. H., Davis, S. A., & Houranieh, A. M. (2013) · Epilepsia · doi:10.1111/epi.12351 · Cited by 88
A prospective study of thiazide use and fractures in women
Feskanich, D., Willett, W. C., Stampfer, M. J., & Colditz, G. A. (1997) · Osteoporosis International · doi:10.1007/bf01623465 · Cited by 88
Solomon, D. H., Diem, S. J., Ruppert, K. M., Lian, Y., Liu, C.-C., Wohlfart, A., Greendale, G. A., & Finkelstein, J. S. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2344 · Cited by 86
Terpos, E., Fragiadaki, K., Konsta, M. A. P., Bratengeier, C., Παπαθεοδώρου, Α., & Sfikakis, P. P. (2011) · PubMed · Cited by 84
Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells
Godschalk, M., Levy, J. R., & Downs, R. W. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070105 · Cited by 83
Bone disease in idiopathic hypercalciuria
Heilberg, I. P., & Weisinger, J. R. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000232880.58340.0c · Cited by 82
Ezri, J., Marques-Vidal, P. M., & Nydegger, A. (2012) · Digestion · doi:10.1159/000336766 · Cited by 82
Orcel, P., Denne, M. A., & de Vernejoul, M. C. (1991) · Endocrinology · doi:10.1210/endo-128-3-1638 · Cited by 81
Smith, M. R., Malkowicz, S. B., Chu, F. M., Forrest, J. B., SIEBER, P. R., Barnette, K. G., Rodriquez, D., & Steiner, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5517 · Cited by 80
Pathological fractures in epilepsy
Sheth, R. D., Gidal, B. E., & Hermann, B. P. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.08.003 · Cited by 77
Fracture risk in patients with prostate cancer on androgen deprivation therapy
López, A. M., Pena, M. Á., Hernández, R., Val, F., Martín, B., & Riancho, J. A. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1799-7 · Cited by 75
Loop Diuretic Use and Fracture in Postmenopausal Women: Findings From the Women's Health Initiative
Carbone, L. D., Johnson, K., Bush, A. J., Robbins, J., Larson, J. C., Thomas, A. M., & LaCroix, A. Z. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.526 · Cited by 74
Marshall, A. G., Kavanagh, R. T., & Crisp, A. J. (1997) · British journal of rheumatology · doi:10.1093/rheumatology/36.3.393 · Cited by 74
Pathogenesis of Osteopenia/Osteoporosis Induced by Highly Active Anti‐Retroviral Therapy for AIDS
Pan, G., Yang, Z., Ballinger, S. W., & McDonald, J. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.057 · Cited by 73
Berenson, J. R., Yellin, O., Boccia, R. V., Flam, M. S., Wong, S., Batuman, O., Moezi, M. M., Woytowitz, D., Duvivier, H. L., Nassir, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0666 · Cited by 72
Compromised Peak Bone Mass in Patients with Inflammatory Bowel Disease–A Prospective Study
Laakso, S. M., Valta, H., Verkasalo, M. A., et al. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.01.073 · Cited by 71
Haemochromatosis: The bone and the joint
Guggenbuhl, P., Brissot, P., & Loréal, O. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.014 · Cited by 69
Approach to the Prostate Cancer Patient with Bone Disease
Greenspan, S. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1402 · Cited by 69
Stefano, M. D., Mengoli, C., Bergonzi, M., & Corazza, G. R. (2013) · Nutrients · doi:10.3390/nu5114786 · Cited by 67
von Bubnoff, N. C. C., Gorantla, S., Kancha, R. K., Lordick, F., Peschel, C., & Duyster, J. (2005) · Leukemia · doi:10.1038/sj.leu.2403887 · Cited by 67
Journal of Bone and Mineral Research
Shane, E. J. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650061427 · Cited by 66
Rabenhorst, A., Christopeit, B., Leja, S., Gerbaulet, A., Kleiner, S., Förster, A., Raap, U., Wickenhauser, C., & Hartmann, K. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.06.019 · Cited by 66
A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men
Brumsen, C., Papapoulos, S. E., Lentjes, E. G. W. M., Kluin, P. M., & Hamdy, N. A. T. (2002) · Bone · doi:10.1016/s8756-3282(02)00875-x · Cited by 66
Secondary contributors to bone loss in osteoporosis related hip fractures
Edwards, B. J.-A., Langman, C. B., Bunta, A. D., Vicuna, M., & Favus, M. J. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0525-7 · Cited by 64
Lopes, L. H. C., Sdepanian, V. L., Szejnfeld, V. L., de Morais, M. B., & Fagundes‐Neto, U. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0223-0 · Cited by 63
The Use of Aromatase Inhibitors for Ovulation Induction and Superovulation
Pavone, M. E., & Bulun, S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1328 · Cited by 63
Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment
Parés, A., & Guañabens, N. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.005 · Cited by 63
Hidalgo, A. A., Deeb, K. K., Pike, J. W., Johnson, C. S., & Trump, D. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244061 · Cited by 63
Bone health in multiple sclerosis
Gibson, J. C., & Summers, G. D. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1644-8 · Cited by 60
Gatta, A., Verardo, A., Pascoli, M. D., Giannini, S., & Bolognesi, M. (2014) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2014.11.3.185 · Cited by 59
Christiansen, P. (2001) · PubMed · Cited by 58
Cited by
Osteoblast-Osteoclast Communication and Bone Homeostasis
Kim, J.-M., Lin, C., Stavre, Z., Greenblatt, M. B., & Shim, J.-H. (2020) · Cells · doi:10.3390/cells9092073 · Cited by 1,178
Zhong, L., Yao, L., Tower, R. J., Wei, Y., Miao, Z., Park, J., Shrestha, R., Wang, L., Yu, W., Holdreith, N., et al. (2020) · eLife · doi:10.7554/elife.54695 · Cited by 335
Pathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people
Barnsley, J., Buckland, G., Chan, P. E., Ong, A., Ramos, A. S., Baxter, M., Laskou, F., Dennison, E. M., Cooper, C., & Patel, H. P. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01817-y · Cited by 199
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Factors influencing peak bone mass gain
Zhu, X., & Zheng, H. (2021) · Frontiers of Medicine · doi:10.1007/s11684-020-0748-y · Cited by 160
Metadata
- Authors
- Mirza, F., & Canalis, E.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-09
- Volume
- 173
- Issue
- 3
- Pages
- R131-R151
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2131332344
- Cited by
- 331
- References
- 241
- FWCI
- 16.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.